Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

BACKGROUND: The main objective of the present study was to establish the relationships between CA-125 kinetics and tumour size changes during treatment. METHODS: The data from the CALYPSO-randomised phase III trial, comparing two platinum-based regimens in recurrent ovarian cancer (ROC) patients, wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilbaux, M, Hénin, E, Oza, A, Colomban, O, Pujade-Lauraine, E, Freyer, G, Tod, M, You, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960627/
https://www.ncbi.nlm.nih.gov/pubmed/24556626
http://dx.doi.org/10.1038/bjc.2014.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960627/
https://www.ncbi.nlm.nih.gov/pubmed/24556626
http://dx.doi.org/10.1038/bjc.2014.75

Ejemplares similares